| Literature DB >> 30497676 |
Abstract
Merkel cell carcinoma is a rare and aggressive cutaneous malignancy of neuroendocrine origin-an often-missed diagnosis due to the wide histopathologic differential diagnosis of malignant small blue cell tumors. The advent of electron microscopy and immunohistochemistry staining for cytokeratin 20, a shared neuroendocrine marker, greatly improved diagnostic accuracy. Over the past decade, staging, treatment, and surveillance of the cancer have progressed at a remarkably rapid pace. Herein, the authors provide an update on the current guidelines around diagnosis and management and review the exciting advancements on the horizon.Entities:
Keywords: Guidelines; Immunotherapy; Merkel cell carcinoma; Merkel cell polyomavirus; Neuroendocrine tumor
Mesh:
Substances:
Year: 2019 PMID: 30497676 DOI: 10.1016/j.hoc.2018.08.002
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN: 0889-8588 Impact factor: 3.722